Dishman Carbogen Amcis Financial Statements
- Switch to
-
Tabular DataGraph
- Switch to
-
ConsolidatedStandalone
Y/e 31 Mar | - | - | - | - |
---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | -- | -- | -- | -- |
Op profit growth | -- | -- | -- | -- |
EBIT growth | -- | -- | -- | -- |
Net profit growth | -- | -- | -- | -- |
Profitability ratios (%) | ||||
OPM | -- | -- | -- | -- |
EBIT margin | -- | -- | -- | -- |
Net profit margin | -- | -- | -- | -- |
RoCE | -- | -- | -- | -- |
RoNW | -- | -- | -- | -- |
RoA | -- | -- | -- | -- |
Per share ratios () | ||||
EPS | -- | -- | -- | -- |
Dividend per share | -- | -- | -- | -- |
Cash EPS | -- | -- | -- | -- |
Book value per share | -- | -- | -- | -- |
Valuation ratios | ||||
P/E | -- | -- | -- | -- |
P/CEPS | -- | -- | -- | -- |
P/B | -- | -- | -- | -- |
EV/EBIDTA | -- | -- | -- | -- |
Payout (%) | ||||
Dividend payout | -- | -- | -- | -- |
Tax payout | -- | -- | -- | -- |
Liquidity ratios | ||||
Debtor days | -- | -- | -- | -- |
Inventory days | -- | -- | -- | -- |
Creditor days | -- | -- | -- | -- |
Leverage ratios | ||||
Interest coverage | -- | -- | -- | -- |
Net debt / equity | -- | -- | -- | -- |
Net debt / op. profit | -- | -- | -- | -- |
Cost breakup () | ||||
Material costs | -- | -- | -- | -- |
Employee costs | -- | -- | -- | -- |
Other costs | -- | -- | -- | -- |
- Switch to
-
Tabular DataGraph
- Switch to
-
ConsolidatedStandalone
Y/e 31 Mar( In .Cr) | Mar-2020 | Mar-2018 | Mar-2017 | Mar-2013 |
---|---|---|---|---|
Revenue | 2,044 | 1,695 | 1,714 | 1,272 |
yoy growth (%) | 20.60 | (1.10) | 34.70 | 13.20 |
Raw materials | (434) | (337) | (329) | (376) |
As % of sales | 21.20 | 19.90 | 19.20 | 29.50 |
Employee costs | (762) | (625) | (596) | (351) |
As % of sales | 37.30 | 36.90 | 34.80 | 27.60 |
Other costs | (325) | (287) | (335) | (255) |
As % of sales | 15.90 | 16.90 | 19.50 | 20.10 |
Operating profit | 522 | 445 | 453 | 290 |
OPM | 25.60 | 26.30 | 26.50 | 22.80 |
Depreciation | (283) | (211) | (214) | (84) |
Interest expense | (62) | (49) | (49) | (79) |
Other income | 44.50 | 45.70 | 26.10 | 17.80 |
Profit before tax | 222 | 231 | 217 | 145 |
Taxes | (42) | (76) | (71) | (45) |
Tax rate | (19) | (33) | (33) | (31) |
Minorities and other | -- | -- | -- | -- |
Adj. profit | 180 | 155 | 146 | 100 |
Exceptional items | -- | -- | -- | -- |
Net profit | 180 | 155 | 145 | 100 |
yoy growth (%) | 16.60 | 6.28 | 45 | 76.70 |
NPM | 8.82 | 9.12 | 8.49 | 7.88 |
- Switch to
-
Tabular DataGraph
Y/e 31 Mar ( In .Cr) | Mar-2020 | Mar-2018 | Mar-2017 | - |
---|---|---|---|---|
Profit before tax | 222 | 231 | 217 | -- |
Depreciation | (283) | (211) | (214) | -- |
Tax paid | (42) | (76) | (71) | -- |
Working capital | 268 | -- | -- | -- |
Other operating items | -- | -- | -- | -- |
Operating cashflow | 166 | (57) | -- | -- |
Capital expenditure | 1,703 | -- | -- | -- |
Free cash flow | 1,868 | (57) | -- | -- |
Equity raised | 10,371 | 9,996 | -- | -- |
Investments | 151 | -- | -- | -- |
Debt financing/disposal | 960 | 346 | -- | -- |
Dividends paid | -- | -- | 19.40 | -- |
Other items | -- | -- | -- | -- |
Net in cash | 13,350 | 10,285 | -- | -- |
- Switch to
-
Tabular DataGraph
- Switch to
-
ConsolidatedStandalone
Y/e 31 Mar ( In .Cr) | Mar-2020 | Mar-2019 | Mar-2018 | Mar-2017 |
---|---|---|---|---|
Equity capital | 31.40 | 32.30 | 32.30 | -- |
Preference capital | -- | -- | -- | -- |
Reserves | 5,706 | 5,347 | 5,075 | 4,814 |
Net worth | 5,738 | 5,379 | 5,107 | 4,814 |
Minority interest | ||||
Debt | 1,357 | 1,042 | 1,095 | 950 |
Deferred tax liabilities (net) | 368 | 368 | 347 | 316 |
Total liabilities | 7,463 | 6,790 | 6,549 | 6,079 |
Fixed assets | 5,912 | 5,273 | 5,217 | 4,985 |
Intangible assets | ||||
Investments | 191 | 167 | 196 | 39.60 |
Deferred tax asset (net) | 226 | 236 | 222 | 235 |
Net working capital | 973 | 1,018 | 845 | 732 |
Inventories | 607 | 549 | 485 | 427 |
Inventory Days | 108 | -- | 104 | 90.90 |
Sundry debtors | 577 | 445 | 444 | 286 |
Debtor days | 103 | -- | 95.70 | 60.80 |
Other current assets | 771 | 791 | 759 | 750 |
Sundry creditors | (284) | (195) | (186) | (86) |
Creditor days | 50.60 | -- | 40 | 18.20 |
Other current liabilities | (699) | (572) | (656) | (645) |
Cash | 161 | 95.70 | 69.10 | 87.40 |
Total assets | 7,463 | 6,790 | 6,549 | 6,079 |
- Switch to
-
ConsolidatedStandalone
Particulars ( Rupees In Crores.) | Mar-2020 | Mar-2019 | Mar-2018 | Mar-2017 | - |
---|---|---|---|---|---|
Gross Sales | 1,973 | 1,920 | 1,653 | 1,634 | -- |
Excise Duty | -- | -- | -- | -- | -- |
Net Sales | 1,973 | 1,920 | 1,653 | 1,634 | -- |
Other Operating Income | 70.30 | 139 | 42.10 | 79.80 | -- |
Other Income | 44.50 | 53.80 | 45.70 | 26.10 | -- |
Total Income | 2,088 | 2,112 | 1,740 | 1,740 | -- |
Total Expenditure ** | 1,546 | 1,507 | 1,249 | 1,261 | -- |
PBIDT | 542 | 606 | 491 | 479 | -- |
Interest | 62 | 56.60 | 48.80 | 49 | -- |
PBDT | 480 | 549 | 442 | 430 | -- |
Depreciation | 283 | 240 | 211 | 214 | -- |
Minority Interest Before NP | -- | -- | -- | -- | -- |
Tax | 27 | 89.10 | 48.70 | 55.40 | -- |
Deferred Tax | 11.70 | 9.40 | 27.50 | 15.30 | -- |
Reported Profit After Tax | 159 | 210 | 155 | 145 | -- |
Minority Interest After NP | -- | -- | -- | -- | -- |
Net Profit after Minority Interest | 159 | 210 | 155 | 145 | -- |
Extra-ordinary Items | -- | -- | -- | -- | -- |
Adjusted Profit After Extra-ordinary item | 159 | 210 | 155 | 145 | -- |
EPS (Unit Curr.) | 10.10 | 13 | 9.58 | 9.01 | -- |
Book Value (Unit Curr.) | -- | -- | -- | -- | -- |
Dividend (%) | -- | 10 | -- | 60 | -- |
Equity | 31.40 | 32.30 | 32.30 | 32.30 | -- |
Public Shareholding (Number) | -- | -- | -- | -- | -- |
Public Shareholding (%) | -- | -- | -- | -- | -- |
Pledged/Encumbered - No. of Shares | -- | -- | -- | -- | -- |
Pledged/Encumbered - % in Total Promoters Holding | -- | -- | -- | -- | -- |
Pledged/Encumbered - % in Total Equity | -- | -- | -- | -- | -- |
Non Encumbered - No. of Shares | -- | -- | -- | -- | -- |
Non Encumbered - % in Total Promoters Holding | -- | -- | -- | -- | -- |
Non Encumbered - % in Total Equity | -- | -- | -- | -- | -- |
PBIDTM(%) | 27.50 | 31.50 | 29.70 | 29.30 | -- |
PBDTM(%) | 24.30 | 28.60 | 26.80 | 26.30 | -- |
PATM(%) | 8.03 | 11 | 9.35 | 8.90 | -- |